Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Tobin Klusty

Biographic Data

ID8306805
NAMETobin Klusty
GIVEN NAMESTobin
FAMILY NAMEKlusty
SIGNATUREKLUSTY T
AFFILIATIONSDePaul University
VERIFIEDNo
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2015
LATEST PUBLICATION YEAR2015
H-INDEX0
  • King v. Burwell

    Open Access•Tobin Klusty, Stephanie Bi•ARTICLE•The AMA Journal of Ethic•2015

    On the morning

  • A Legal Test for the Pharmaceutical Company Practice of “Product Hopping”

    Open Access•Tobin Klusty•ARTICLE•The AMA Journal of Ethic•2015

    In New York v. Actavis, the Second Circuit’s ruling forbids product hopping, or extending the monopoly of a patented drug by introducing a new formulation of the drug and discontinuing an older one, if there is evidence that the strategy is coercive and used to restrict fair competition

  • Forced Sterilizations of HIV-Positive Women

    Open Access•Stephanie Bi, Tobin Klusty•ARTICLE•The AMA Journal of Ethic•2015

    Forced sterilization of HIV-positive women, which is widespread in South Africa, Namibia, and Chile, violates women’s human right to autonomy and the principle of informed consent and is medically unnecessary

  • Supreme Court to Myriad Genetics

    Open Access•Tobin Klusty, Richard Weinmeyer•ARTICLE•The AMA Journal of Ethic•2015

    Ever since James Watson and Francis Crick presented the double-helix structure of DNA to the world in 1953, genetic research-and its contribution to medical science-has become an invaluable tool for understanding and fighting disease. The research has also sparked a race to publish, patent, and profit from discoveries to gain an advantage in a scientific marketplace in which time and money are finite resources and companies are made and others di…

No prominent works on this page.

  • King v. Burwell

    Open Access•Tobin Klusty, Stephanie Bi•ARTICLE•The AMA Journal of Ethic•2015

    On the morning

  • A Legal Test for the Pharmaceutical Company Practice of “Product Hopping”

    Open Access•Tobin Klusty•ARTICLE•The AMA Journal of Ethic•2015

    In New York v. Actavis, the Second Circuit’s ruling forbids product hopping, or extending the monopoly of a patented drug by introducing a new formulation of the drug and discontinuing an older one, if there is evidence that the strategy is coercive and used to restrict fair competition

  • Forced Sterilizations of HIV-Positive Women

    Open Access•Stephanie Bi, Tobin Klusty•ARTICLE•The AMA Journal of Ethic•2015

    Forced sterilization of HIV-positive women, which is widespread in South Africa, Namibia, and Chile, violates women’s human right to autonomy and the principle of informed consent and is medically unnecessary

  • Supreme Court to Myriad Genetics

    Open Access•Tobin Klusty, Richard Weinmeyer•ARTICLE•The AMA Journal of Ethic•2015

    Ever since James Watson and Francis Crick presented the double-helix structure of DNA to the world in 1953, genetic research-and its contribution to medical science-has become an invaluable tool for understanding and fighting disease. The research has also sparked a race to publish, patent, and profit from discoveries to gain an advantage in a scientific marketplace in which time and money are finite resources and companies are made and others di…

Business (3 works) · Political science (3 works) · Biomedical Ethics and Regulation (2 works) · Intellectual Property and Patents (2 works) · Law (2 works) · Supreme court (2 works) · Actuarial science (1 work) · Biology (1 work) · Computational biology (1 work) · Economics (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae